Graham Juan's Form 4 filing
Kyntra Bio, Inc. (KYNB) · filed Mar 10, 2023
- Accession no.
- 0001209191-23-018062
- Filed
- Mar 10, 2023
- Trade date
- Mar 8-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $157.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Graham JuanCIK 0001879223 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Common Stock | SSaleDisposed | −2,749 | $21.16 | −$58,168.84 | 70,213 | Direct | |
| Mar 8, 2023 | Common Stock | AGrant or awardAcquired | +2,899 | $0.00 | $0 | 73,112 | Direct | |
| Mar 8, 2023 | Common Stock | AGrant or awardAcquired | +4,668 | $0.00 | $0 | 77,780 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −1,112 | $20.20 | −$22,462.4 | 76,668 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −1,456 | $20.20 | −$29,411.2 | 75,212 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −2,344 | $20.20 | −$47,348.8 | 72,868 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.